Galderma Group AG (GALD) Stock Forecast & Price Target

Compare

11 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GALD Analyst Ratings

Strong Buy

6 Buy

1 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Galderma

Group AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GALD Stock 12 Month Forecast

Average Price Target

CHF180.57

▲(18.80% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Galderma Group AG in the last 3 months. The average price target is CHF180.57 with a high forecast of CHF200.00 and a low forecast of CHF140.00. The average price target represents a 18.80% change from the last price of CHF152.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"94":"CHF94","201":"CHF201","120.75":"CHF120.8","147.5":"CHF147.5","174.25":"CHF174.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF200.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":180.57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF180.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":140,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF140.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[94,120.75,147.5,174.25,201],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,162.1,165.01538461538462,167.93076923076922,170.84615384615384,173.76153846153846,176.67692307692306,179.59230769230768,182.5076923076923,185.4230769230769,188.33846153846153,191.25384615384615,194.16923076923075,197.08461538461538,{"y":200,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,162.1,163.52076923076922,164.94153846153844,166.3623076923077,167.78307692307692,169.20384615384614,170.62461538461537,172.04538461538462,173.46615384615384,174.88692307692307,176.3076923076923,177.72846153846154,179.14923076923077,{"y":180.57,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,162.1,160.4,158.7,157,155.29999999999998,153.6,151.9,150.2,148.5,146.8,145.1,143.4,141.7,{"y":140,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":100.47,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.52,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":109.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.27,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":139.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.1,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF200.00

Average Price TargetCHF180.57

Lowest Price TargetCHF140.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Justine Telliez

Kepler Capital

CHF167

Buy

9.87%

Upside

Reiterated

01/22/26

Benjamin Jackson CFA

Jefferies

CHF190

Buy

25.00%

Upside

Reiterated

01/21/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Qiagen (NYSE: QGEN), Galderma Group AG (Six Swiss: CH:GALD) and DocMorris (Six Swiss: CH:DOCM)

Bethan Davies

Berenberg Bank

CHF184→CHF187

Buy

23.03%

Upside

Reiterated

01/13/26

Galderma Group AG (GALD) Gets a Buy from Berenberg Bank

Matthew Weston

UBS

CHF190→CHF200

Buy

31.58%

Upside

Reiterated

01/08/26

UBS Sticks to Its Buy Rating for Galderma Group AG (GALD)

Chris Shibutani

Goldman Sachs

CHF167→CHF185

Buy

21.71%

Upside

Reiterated

01/06/26

Goldman Sachs Sticks to Its Buy Rating for Galderma Group AG (GALD)

Yihan Li

Barclays

CHF155

Buy

1.97%

Upside

Reiterated

12/08/25

Barclays Sticks to Their Buy Rating for Galderma Group AG (GALD)

Natalia Webster

RBC Capital

CHF140

Hold

-7.89%

Downside

Reiterated

10/29/25

RBC Capital Remains a Hold on Galderma Group AG (GALD)

Cedric Besnard

Citi

CHF140→CHF165

Buy

8.55%

Upside

Reiterated

10/24/25

Citi Remains a Buy on Galderma Group AG (GALD)

Thibault Boutherin

Morgan Stanley

CHF135

Hold

-11.18%

Downside

Reiterated

10/23/25

Galderma Group AG: Strong Q3 Performance Amid Market Challenges, Hold Rating Reflects Balanced Outlook

Unknown Analyst

Bank Vontobel

Not Ranked

Bank Vontobel

Buy

―

Upgraded

10/06/25

Galderma Group AG (GALD) was upgraded to a Buy Rating at Bank Vontobel

James Gordon

J.P. Morgan

CHF120→CHF160

Buy

5.26%

Upside

Reiterated

07/25/25

J.P. Morgan Reaffirms Their Buy Rating on Galderma Group AG (GALD)

Unknown Analyst

William O'Neil

Not Ranked

William O'Neil

Buy

―

Initiated

07/09/25

Galderma Group AG (GALD) Has a New Rating from William O'Neil

Unknown Analyst

Peel Hunt

Not Ranked

Peel Hunt

Buy

―

Reiterated

06/30/25

Peter Verdult

Exane BNP Paribas

CHF100

Buy

-34.21%

Downside

Initiated

04/16/25

BNP Paribas Exane Starts Galderma Group AG (GALD:SW) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Galderma Group AG (GALD:SW) with a Outperform rating and a price target of CHF100.00.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Justine Telliez

Kepler Capital

CHF167

Buy

9.87%

Upside

Reiterated

01/22/26

Benjamin Jackson CFA

Jefferies

CHF190

Buy

25.00%

Upside

Reiterated

01/21/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Qiagen (NYSE: QGEN), Galderma Group AG (Six Swiss: CH:GALD) and DocMorris (Six Swiss: CH:DOCM)

Bethan Davies

Berenberg Bank

CHF184→CHF187

Buy

23.03%

Upside

Reiterated

01/13/26

Galderma Group AG (GALD) Gets a Buy from Berenberg Bank

Matthew Weston

UBS

CHF190→CHF200

Buy

31.58%

Upside

Reiterated

01/08/26

UBS Sticks to Its Buy Rating for Galderma Group AG (GALD)

Chris Shibutani

Goldman Sachs

CHF167→CHF185

Buy

21.71%

Upside

Reiterated

01/06/26

Goldman Sachs Sticks to Its Buy Rating for Galderma Group AG (GALD)

Yihan Li

Barclays

CHF155

Buy

1.97%

Upside

Reiterated

12/08/25

Barclays Sticks to Their Buy Rating for Galderma Group AG (GALD)

Natalia Webster

RBC Capital

CHF140

Hold

-7.89%

Downside

Reiterated

10/29/25

RBC Capital Remains a Hold on Galderma Group AG (GALD)

Cedric Besnard

Citi

CHF140→CHF165

Buy

8.55%

Upside

Reiterated

10/24/25

Citi Remains a Buy on Galderma Group AG (GALD)

Thibault Boutherin

Morgan Stanley

CHF135

Hold

-11.18%

Downside

Reiterated

10/23/25

Galderma Group AG: Strong Q3 Performance Amid Market Challenges, Hold Rating Reflects Balanced Outlook

Unknown Analyst

Bank Vontobel

Not Ranked

Bank Vontobel

Buy

―

Upgraded

10/06/25

Galderma Group AG (GALD) was upgraded to a Buy Rating at Bank Vontobel

James Gordon

J.P. Morgan

CHF120→CHF160

Buy

5.26%

Upside

Reiterated

07/25/25

J.P. Morgan Reaffirms Their Buy Rating on Galderma Group AG (GALD)

Unknown Analyst

William O'Neil

Not Ranked

William O'Neil

Buy

―

Initiated

07/09/25

Galderma Group AG (GALD) Has a New Rating from William O'Neil

Unknown Analyst

Peel Hunt

Not Ranked

Peel Hunt

Buy

―

Reiterated

06/30/25

Peter Verdult

Exane BNP Paribas

CHF100

Buy

-34.21%

Downside

Initiated

04/16/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Galderma Group AG

3 Months

xxx

Success Rate

4/4 ratings generated profit

Average Return

+20.40%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +20.40% per trade.

1 Year

Bethan DaviesBerenberg Bank

Success Rate

5/5 ratings generated profit

Average Return

+48.12%

reiterated a buy rating 11 days ago

Copying Bethan Davies's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +48.12% per trade.

2 Years

xxx

Success Rate

5/5 ratings generated profit

Average Return

+48.12%

reiterated a xxx

rating 11 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +48.12% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GALD Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GALD has received 18 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GALD average Analyst price target in the past 3 months is 180.57.

Each month's total comprises the sum of three months' worth of ratings.

GALD Financial Forecast

GALD Earnings Forecast

Next quarter’s earnings estimate for GALD is CHF1.26 with a range of CHF0.87 to CHF1.44. The previous quarter’s EPS was CHF1.11. GALD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.16% of the time in the same period. In the last calendar year GALD has Performed in-line its overall industry.

GALD Sales Forecast

Next quarter’s sales forecast for GALD is CHF1.10B with a range of CHF1.09B to CHF1.11B. The previous quarter’s sales results were CHF2.11B. GALD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.92% of the time in the same period. In the last calendar year GALD has Performed in-line its overall industry.

GALD Stock Forecast FAQ

What is CH:GALD’s average 12-month price target, according to analysts?

Based on analyst ratings, Galderma Group AG’s 12-month average price target is 180.57.

What is CH:GALD’s upside potential, based on the analysts’ average price target?

Galderma Group AG has 18.80% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CH:GALD a Buy, Sell or Hold?

Galderma Group AG has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.

What is Galderma Group AG’s price target?

The average price target for Galderma Group AG is 180.57. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is CHF200.00 ,the lowest forecast is CHF140.00. The average price target represents 18.80% Increase from the current price of CHF152.

What do analysts say about Galderma Group AG?

Galderma Group AG’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of CH:GALD?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Galderma Group AG (GALD) Stock Forecast & Price Target

GALD Analyst Ratings

GALD Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Galderma Group AG

GALD Analyst Recommendation Trends

GALD Financial Forecast

GALD Earnings Forecast

GALD Sales Forecast

GALD Stock Forecast FAQ

Detailed List of Analyst Forecasts